The independent source for health policy research, polling, and news.
41 - 60 of 112,894 Results
Stanford researchers found that in 2024, more than two-thirds of new drugs approved by the FDA were sanctioned based on findings from a single study, CIDRAP reported. The findings also show a sharp increase in industry-sponsored studies. The senior author of the analysis called the results "concerning, as it allows products to reach the market without independent confirmation of the findings.”
The cyclosporiasis outbreak has laid bare the shortcomings at the Food and Drug Administration, which lost inspectors during the covid pandemic and never recovered. Food experts say inspectors should have been on-site in Mexico at the farm tied to tainted lettuce sooner, considering the scale and number of people sickened, the AP reported.
"Where the Clinic Meets the Movement: Does Gender Ideology Arm Left-Wing Authoritarian Psychology?" — essentially a political ideology questionnaire, The Guardian reported — was neither peer-reviewed as required by law nor published by a scientific journal. “What we’re seeing is this broadside attack on the scientific establishment more generally, and trans rights are being used as the vehicle to do this,” one professor noted. Experts worry the administration might use the study to further its anti-trans campaign, The 19th reported.
Today's early morning highlights from the major news organizations.
Opinion writers examine these public health issues.
Each week, KFF Health News finds longer stories for you to enjoy. Today's selections are on grief, ASL, aging, bird flu, a man who lived with wolves, and more.
The California Office of Health Care Affordability voted unanimously Wednesday to discipline those who overspend, Modern Healthcare reported. Additionally, those who repeatedly fail to file acceptable performance improvement plans, don't implement corrective action plans, or falsify information could also face fines.
Health, advanced digital technologies, and the environment are among the priority fields set out by the Canadian government to receive funding for research projects, Bloomberg reported. After promising an accelerated immigration pathway for H-1B visa holders last year, Canada is poaching some 48 U.S. researchers from elite institutions such as Harvard University and MIT.
The CDC's chief operating officer, Sean Slovenski, announced the project in an email late last week, MedPage Today reported. The initiative aims to focus on emergency public health responses and infectious diseases, as well as "immediate improvements" to "simplify processes, reduce administrative burden, and remove barriers to advancing mission-critical work."
Amid a swelling measles outbreak, the top public health officials are accusing Gov. Josh Shapiro, a Democrat, of withholding information about the cases and are questioning whether measles caused the deaths. The Pennsylvania Health Department disputes those claims. The Lancaster County coroner said a newborn, who had evidence of the virus in lung tissue, suffered a ruptured spleen.
The research, released Thursday in the journal Science, is a map of the genetic mutations associated with autism and how they affect the brain. Scientists hope to use this map to develop more targeted therapies.
Tulane University has announced that it is spearheading a $500 million effort to convert the building that once housed Charity Hospital into a pioneering medical research facility, AP reported. It has been shut for over two decades after the devastation of Hurricane Katrina.
People 65 and older qualify for the shots, as do people who have an increased risk of severe infection. Off-label vaccines could be available to others, but some states don't permit pharmacists to give shots that haven't been OK'd by the CDC. The Advisory Committee on Immunization Practices, still in legal limbo, has not made a recommendation about whether the shots should be covered by insurance.
Note to readers: First Edition will be on hiatus from Monday, Aug. 31 through Monday, Sept. 7. We'll return to your inbox Sept. 8.
Here are today's early morning highlights from the major news organizations.
Editorial writers tackle these public health topics.
Each week, KFF Health News compiles a selection of health policy studies and briefs.
According to Modern Healthcare, the Mississippi Insurance Department is preparing to spend $20 million in state funds to launch the “Mississippi Option” next year. The portal for short-term plans, ineligible for federal subsidies, features scaled-back prescription drug coverage and could help thousands of middle-class residents who can’t afford the premiums for health insurance exchange policies.
Earlier this month PatientRightsAdvocate.org sued the American Medical Association in federal court, claiming that it "has no valid copyright" and "has no right to withhold [Current Procedural Terminology] from the public and charge hefty fees for access," MedPage Today reported. An AMA spokesperson said it will "vigorously defend the AMA's intellectual property rights to ensure the continued access physicians and patients rely on."
People in the Make America Healthy Again movement point to Heidi Overton's role in President Donald Trump's executive order to spur production of a pesticide as a red flag that should sink her confirmation, The Washington Post reported. The White House says that Overton played only a bit role at the end of the process and that she “pushed as many MAHA-minded edits as possible."
In a landmark settlement, Meta said it would pay up to $18 billion and establish restrictions for teen users, including daily usage limits, blocks on nighttime use, and disabling “like” counts. However, some teens shrugged at the news, telling The New York Times, “If anything, it’s just going to make kids fake their age more.”
© 2026 KFF